OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial
Jane Yardley, Mikko Kärppä, Yuichi Inoue, et al.
Sleep Medicine (2021) Vol. 80, pp. 333-342
Open Access | Times Cited: 59
Jane Yardley, Mikko Kärppä, Yuichi Inoue, et al.
Sleep Medicine (2021) Vol. 80, pp. 333-342
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
Dieter Kunz, Yves Dauvilliers, Heike Beneš, et al.
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 93-106
Open Access | Times Cited: 52
Dieter Kunz, Yves Dauvilliers, Heike Beneš, et al.
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 93-106
Open Access | Times Cited: 52
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia
Nathaniel F. Watson, Ruth M. Benca, Andrew D. Krystal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2493-2493
Open Access | Times Cited: 18
Nathaniel F. Watson, Ruth M. Benca, Andrew D. Krystal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2493-2493
Open Access | Times Cited: 18
Treatment strategy for insomnia disorder: Japanese expert consensus
Yoshikazu Takaesu, Hitoshi Sakurai, Yumi Aoki, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 16
Yoshikazu Takaesu, Hitoshi Sakurai, Yumi Aoki, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 16
Emerging and upcoming therapies in insomnia
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder
Valerie Arnold, Sonia Ancoli‐Israel, Thien Thanh Dang‐Vu, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1081-1098
Open Access | Times Cited: 6
Valerie Arnold, Sonia Ancoli‐Israel, Thien Thanh Dang‐Vu, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1081-1098
Open Access | Times Cited: 6
Navigating the evolving landscape in the prescribing of medications for insomnia in Singapore: Principles and considerations from a psychiatrist’s perspective
Ho Teck Tan, Chao Tian Tang, Shian Ming Tan
Annals of the Academy of Medicine Singapore (2025) Vol. 54, Iss. 1, pp. 53-56
Open Access
Ho Teck Tan, Chao Tian Tang, Shian Ming Tan
Annals of the Academy of Medicine Singapore (2025) Vol. 54, Iss. 1, pp. 53-56
Open Access
Pharmacological management of chronic insomnia disorder in Singapore: Recommendations from an expert panel
Roger Ho, Chau Sian Lim, Norman Sartorius, et al.
Proceedings of Singapore Healthcare (2025) Vol. 34
Open Access
Roger Ho, Chau Sian Lim, Norman Sartorius, et al.
Proceedings of Singapore Healthcare (2025) Vol. 34
Open Access
MR Imaging Indices for Brain Interstitial Fluid Dynamics and the Effects of Orexin Antagonists on Sleep
Toshiaki Taoka, Kunihiro Iwamoto, Seiko Miyata, et al.
Magnetic Resonance in Medical Sciences (2025)
Open Access
Toshiaki Taoka, Kunihiro Iwamoto, Seiko Miyata, et al.
Magnetic Resonance in Medical Sciences (2025)
Open Access
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Mechanistic insights into the interaction between epilepsy and sleep
Laurent Sheybani, Birgit Frauscher, Christophe Bernard, et al.
Nature Reviews Neurology (2025)
Closed Access
Laurent Sheybani, Birgit Frauscher, Christophe Bernard, et al.
Nature Reviews Neurology (2025)
Closed Access
Efficacy and safety of Lemborexant in treating adult patients with insomnia in China: a single-center, retrospective observational study
Weiying Jian, Minyan Feng, Yifan Zhao, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Weiying Jian, Minyan Feng, Yifan Zhao, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder
Thomas Roth, Russell Rosenberg, Charles M. Morin, et al.
Sleep Medicine (2022) Vol. 90, pp. 249-257
Open Access | Times Cited: 16
Thomas Roth, Russell Rosenberg, Charles M. Morin, et al.
Sleep Medicine (2022) Vol. 90, pp. 249-257
Open Access | Times Cited: 16
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users
Ishani Landry, Nancy Hall, Jagadeesh Aluri, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 4, pp. 365-373
Open Access | Times Cited: 16
Ishani Landry, Nancy Hall, Jagadeesh Aluri, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 4, pp. 365-373
Open Access | Times Cited: 16
A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea
Jocelyn Y. Cheng, Daniel Lorch, Alan Lowe, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 20, Iss. 1, pp. 57-65
Closed Access | Times Cited: 9
Jocelyn Y. Cheng, Daniel Lorch, Alan Lowe, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 20, Iss. 1, pp. 57-65
Closed Access | Times Cited: 9
2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association
Luciano F. Drager, Márcia Assis, Andrea Bacelar, et al.
Sleep Science (2023) Vol. 16, Iss. S 02, pp. 507-549
Open Access | Times Cited: 9
Luciano F. Drager, Márcia Assis, Andrea Bacelar, et al.
Sleep Science (2023) Vol. 16, Iss. S 02, pp. 507-549
Open Access | Times Cited: 9
Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials
Mark H. Gotfried, Sanford Auerbach, Thien Thanh Dang‐Vu, et al.
Drugs & Aging (2024) Vol. 41, Iss. 9, pp. 741-752
Open Access | Times Cited: 3
Mark H. Gotfried, Sanford Auerbach, Thien Thanh Dang‐Vu, et al.
Drugs & Aging (2024) Vol. 41, Iss. 9, pp. 741-752
Open Access | Times Cited: 3
Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial
Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 4, pp. 581-592
Open Access | Times Cited: 15
Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 4, pp. 581-592
Open Access | Times Cited: 15
Current and Emerging Sleep Interventions for Older Adults with or without Mild Cognitive Impairment
Anastasia Suraev, Shawn Dexiao Kong, Zoe Menczel Schrire, et al.
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 11, pp. 463-483
Open Access | Times Cited: 2
Anastasia Suraev, Shawn Dexiao Kong, Zoe Menczel Schrire, et al.
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 11, pp. 463-483
Open Access | Times Cited: 2
Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder
Amitabh Dash, Kate Pinner, Yuichi Inoue, et al.
Sleep Medicine X (2022) Vol. 4, pp. 100044-100044
Open Access | Times Cited: 9
Amitabh Dash, Kate Pinner, Yuichi Inoue, et al.
Sleep Medicine X (2022) Vol. 4, pp. 100044-100044
Open Access | Times Cited: 9
